Zolgensma (Onasemnogene Abeparvovec): Uses, Side Effects & Interactions
Zolgensma is a revolutionary, one-time intravenous gene therapy utilizing Onasemnogene Abeparvovec to treat spinal muscular atrophy in pediatric patients. The most critical side effects involve acute hepatotoxicity and profound systemic immune responses, requiring vigilant clinical monitoring and concurrent immunosuppressive therapy. Strict adherence to rigorous pre- and post-infusion medical protocols is essential to ensure patient survival … Read more